EP0820766A3 - Nouvelles compositions topiques comprenant de très faibles doses de mélatonine ou ses dérivés et leur utilisation en cosmétique - Google Patents

Nouvelles compositions topiques comprenant de très faibles doses de mélatonine ou ses dérivés et leur utilisation en cosmétique Download PDF

Info

Publication number
EP0820766A3
EP0820766A3 EP97401632A EP97401632A EP0820766A3 EP 0820766 A3 EP0820766 A3 EP 0820766A3 EP 97401632 A EP97401632 A EP 97401632A EP 97401632 A EP97401632 A EP 97401632A EP 0820766 A3 EP0820766 A3 EP 0820766A3
Authority
EP
European Patent Office
Prior art keywords
melatonin
cosmetics
derivatives
compositions containing
low doses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP97401632A
Other languages
German (de)
English (en)
Other versions
EP0820766B1 (fr
EP0820766A2 (fr
Inventor
Pierre Tachon
Jean-François Nadaud
Francis Pruche
Lionel Breton
Catherine Gerst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494485&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0820766(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP0820766A2 publication Critical patent/EP0820766A2/fr
Publication of EP0820766A3 publication Critical patent/EP0820766A3/fr
Application granted granted Critical
Publication of EP0820766B1 publication Critical patent/EP0820766B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a pour objet de nouvelles compositions dermo-cosmétiques comprenant de la mélatonine ou au moins un de ses analogues à des doses inférieures à 10-4 % et présentant une activité antioxydante améliorée. Elle concerne également leur utilisation en cosmétique pour améliorer ou maintenir l'apparence de la peau ou du scalp.
EP97401632A 1996-07-25 1997-07-08 Nouvelles compositions topiques comprenant de très faibles doses de mélatonine ou ses dérivés et leur utilisation en cosmétique Expired - Lifetime EP0820766B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9609387A FR2751539B1 (fr) 1996-07-25 1996-07-25 Nouvelles compositions topiques comprenant de tres faibles doses de melatonine ou ses derives et leur utilisation en cosmetique
FR9609387 1996-07-25

Publications (3)

Publication Number Publication Date
EP0820766A2 EP0820766A2 (fr) 1998-01-28
EP0820766A3 true EP0820766A3 (fr) 1998-02-04
EP0820766B1 EP0820766B1 (fr) 2003-04-09

Family

ID=9494485

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97401632A Expired - Lifetime EP0820766B1 (fr) 1996-07-25 1997-07-08 Nouvelles compositions topiques comprenant de très faibles doses de mélatonine ou ses dérivés et leur utilisation en cosmétique

Country Status (7)

Country Link
US (1) US5985293A (fr)
EP (1) EP0820766B1 (fr)
JP (1) JP2986432B2 (fr)
CA (1) CA2210674C (fr)
DE (1) DE69720613T2 (fr)
ES (1) ES2196275T3 (fr)
FR (1) FR2751539B1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
CA2415882A1 (fr) * 2000-07-13 2002-01-24 Skinmedica, Inc. Composition destinee a l'administration par voie topique de vitamine c
KR100849916B1 (ko) * 2002-10-30 2008-08-04 아에스아테 아게 어플라이드 사이언스 앤드 테크놀로지 멜라토닌 일일 투여 유닛
US20040120915A1 (en) * 2002-12-19 2004-06-24 Kaiyuan Yang Multifunctional compositions for surface applications
US20050020666A1 (en) * 2003-07-25 2005-01-27 Dabur Research Foundation Cardioprotective agents
GB2434099A (en) * 2006-01-12 2007-07-18 Roger Coghill Very low dosage melatonin compositions and their use in the treatment of the adverse effects of exposure to electromagnetic fields and radiation
ITRM20060108A1 (it) * 2006-03-03 2007-09-04 Colella Gino Composizioni a base di melatonina e sostanze immunostimolanti
JP5054945B2 (ja) * 2006-08-28 2012-10-24 共栄化学工業株式会社 化粧料
EP2196190A1 (fr) * 2008-12-09 2010-06-16 Cognis IP Management GmbH Blanchiment de la peau
US20100256215A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Menthol-Melatonin Dissolving Film
US20100256197A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Nicotine Dissolving Film With Or Without Menthol
ES2378028B1 (es) * 2012-02-22 2013-02-18 Ignacio Umbert Millet Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes
WO2019038586A1 (fr) 2017-08-19 2019-02-28 Ftf Pharma Private Limited Composition pharmaceutique de mélatonine
KR102506059B1 (ko) * 2020-10-20 2023-03-07 코스맥스 주식회사 멜라토닌을 포함하는 항산화용 화장료 조성물

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005093A2 (fr) * 1985-03-04 1986-09-12 Cellena (Cell Engineering) A.G. Compositions de melatonine et leurs utilisations
WO1987000432A2 (fr) * 1985-07-16 1987-01-29 Cellena (Cell Engineering) A.G. Compositions contenant de la melatonine ou ses homologues, leurs utilisations pour le traitement du psoriasis vulgaris et/ou des affections apparentees
WO1993007870A1 (fr) * 1991-10-18 1993-04-29 Alza Corporation Dispositif pour l'administration transdermique de melatonine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
US5560917A (en) * 1995-02-01 1996-10-01 Maybelline Intermediate Company Cosmetic makeup composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005093A2 (fr) * 1985-03-04 1986-09-12 Cellena (Cell Engineering) A.G. Compositions de melatonine et leurs utilisations
WO1987000432A2 (fr) * 1985-07-16 1987-01-29 Cellena (Cell Engineering) A.G. Compositions contenant de la melatonine ou ses homologues, leurs utilisations pour le traitement du psoriasis vulgaris et/ou des affections apparentees
WO1993007870A1 (fr) * 1991-10-18 1993-04-29 Alza Corporation Dispositif pour l'administration transdermique de melatonine

Also Published As

Publication number Publication date
CA2210674A1 (fr) 1998-01-25
ES2196275T3 (es) 2003-12-16
JP2986432B2 (ja) 1999-12-06
FR2751539A1 (fr) 1998-01-30
FR2751539B1 (fr) 1998-12-04
CA2210674C (fr) 2006-11-14
US5985293A (en) 1999-11-16
EP0820766B1 (fr) 2003-04-09
DE69720613T2 (de) 2004-03-25
EP0820766A2 (fr) 1998-01-28
DE69720613D1 (de) 2003-05-15
JPH1067648A (ja) 1998-03-10

Similar Documents

Publication Publication Date Title
ES2162268T3 (es) Composiciones cosmeticas a base de pirazolin-4,5-dionas, nuevas pirazolin-4,5-dionas, procedimientos de preparacion y utilizaciones.
ID21658A (id) Komposisi-komposisi kosmetik untuk perawatan rambut atau kulit yang mengandung fluorokarbon yang diinfus dengan karbondioksida
EP0820766A3 (fr) Nouvelles compositions topiques comprenant de très faibles doses de mélatonine ou ses dérivés et leur utilisation en cosmétique
WO2002030367A3 (fr) Systeme de conditionnement pour objet presentant une forme determinee
BR9712491A (pt) Composições cosméticas
BR9714064A (pt) Composição farmacêutica
SG64325A1 (en) Thermoplastic elasomeric copolymers and hair and skin care compositions containing the same
DE69332875D1 (de) Haarkosmetische Zusammensetzung
ATE299015T1 (de) Hautpflegemitteln enthaltend eine kombination von aktive wirkstoffen
CA2269897A1 (fr) Derives d'aminophenol et leur utilisation en cosmetique
FR2698003B1 (fr) Compose cosmetique, composition cosmetique le comprenant et utilisation de ce compose pour conserver l'humidite de la peau et des cheveux.
FR2746316B1 (fr) Nouvelles compositions cosmetologiques ou dermatologiques
IL130037A0 (en) Use of sphingomyelinase to increase the levels of skin and mucosal cermides and dermatological and cosmetic compositions suitable for topical application containing same
CA2135575A1 (fr) Composition cosmetique contenant en tant qu'agent reducteur un n-mercapto-alkyl alcanediamide ou l'un de ses sels cosmetiquement acceptable
ID23275A (id) Pati turunan tak ionik dan penggunaannya dalam komposisi kosmetik rambut bukan aerosol dengan voc rendah
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
FR2597335B1 (fr) Composition cosmetique permettant de lutter contre l'aspect gras des cheveux, et son utilisation.
DK1089704T3 (da) Hårplejelotion til topisk anvendelse
EP0687467A3 (fr) Préparations cosmétiques et dermatologiques contenant des éthers de glycerylalkyl comme composant actif
DE69521116D1 (de) Haarkosmetische zusammensetzung
AU3003199A (en) Tourmaline in cosmetic cleansing compositions
EP0136914A3 (fr) Compositions de shampooing
CA2207783A1 (fr) Composition desodorisante ou antisudorifique contenant une creme hydratante
IT8520837A0 (it) Composti per uso cosmetico dermatologico e relative composizioni.
KR970703127A (ko) 모발 미용 조성물(hair cosmetic compositions)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE ES FR GB IT

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RTI1 Title (correction)
17P Request for examination filed

Effective date: 19980804

AKX Designation fees paid

Free format text: DE ES FR GB IT

RBV Designated contracting states (corrected)

Designated state(s): DE ES FR GB IT

17Q First examination report despatched

Effective date: 20010803

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): DE ES FR GB IT

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20030728

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2196275

Country of ref document: ES

Kind code of ref document: T3

PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

26 Opposition filed

Opponent name: ASAT AGAPPLIED SCIENCE & TECHNOLOGY

Effective date: 20040108

PLAX Notice of opposition and request to file observation + time limit sent

Free format text: ORIGINAL CODE: EPIDOSNOBS2

PLBB Reply of patent proprietor to notice(s) of opposition received

Free format text: ORIGINAL CODE: EPIDOSNOBS3

PLCK Communication despatched that opposition was rejected

Free format text: ORIGINAL CODE: EPIDOSNREJ1

PLBN Opposition rejected

Free format text: ORIGINAL CODE: 0009273

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: OPPOSITION REJECTED

27O Opposition rejected

Effective date: 20051123

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20070705

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20070824

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20070704

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20070728

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20070710

Year of fee payment: 11

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20080708

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090203

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20090331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080708

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080708

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080731

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20080709

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080709